Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
eCOA technologies are a cornerstone for elevating patient data collection in clinical trials. Beyond collecting patient data, IQVIA eCOA assists in addressing critical pain points across studies, focusing on timelines, processes and patient compliance.
Time is a critical factor in study execution, and at IQVIA, our agile development model stands as a beacon of efficiency. By approaching sponsors with a pre-designed framework and assessments already implemented within the platform, we eliminate the need to start from scratch. This not only accelerates study startup times but also reduces ambiguity when gathering requirements from sponsors. The real-time changes and immediate clarity offered during the process significantly cuts down the need for change orders. Imagine setting up a study in 4-6 weeks instead of the industry-standard 3-4 months, providing sponsors with the agility to pivot based on early feedback from teams, regulators, IRBs and ERBs.
Our commitment to efficiency extends to streamlining study start-up processes through direct collaboration between the sponsor and the eCOA implementation team. Bringing members from both organizations to the table fosters real-time communication, setting expectations and allowing changes to be made promptly. This collaborative approach leads to expedited assessment finalization. The automatic generation of screenshots and instantly producible, ready to submit documentation within the IQVIA eCOA platform further enhances this streamlined process.
Global studies often require assessments in multiple languages, and our approach to translations is a testament to efficiency. Leveraging our library of validated assessments as well as a strategic partnership with translation vendors, we manage the translation process seamlessly. Unlike the traditional 20+ step process with multiple stakeholders and back-and-forth interactions, our approach cuts out the go-between. Translation vendors, directly integrated into our eCOA platform, manage translations based on sponsor needs. This streamlined method results in fewer steps, fewer hand-offs and ultimately, a faster and clearer process.
Recognizing the direct link between ease of participation and patient compliance, our eCOA is designed to support “bring your own device” (BYOD) strategies. This empowers trial participants to use their familiar devices, eliminating the need for multiple devices. The robust reminder, notification and scheduling system within our eCOA platform ensure sponsors can provide patients with ample notice and reminders for upcoming diaries, contributing to increased patient compliance.
Fast, flexible and proven, IQVIA eCOA can cut start-up timelines, innovate processes and focus on patient compliance to assist sponsors in building a patient-centric trial that is built on efficiencies and flexibility. To explore what IQVIA eCOA can do for your next trial, visit us at iqvia.com/eCOA or email us at ecoa@iqvia.com to speak with an IQVIA eCOA expert.
Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
Explore our Frequently Asked Questions (FAQ) page to learn more about general industry eCOA topics and also specific details about our IQVIA eCOA solution.
In these short demo videos, learn more about some of the key capabilities within the IQVIA eCOA platform including how to easily create an assessment, utilize the AI design tool, access automated screenshots and documentation, export/import translations, and view study data and reports.
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
Combine data science, technology, and analytics driven by artificial intelligence to support new efficiencies and business insights -- without additional capital investment.